VYNE Therapeutics Inc.
(VYNE)
undefined
undefined%
At close: undefined
2.56
0.39%
After-hours Dec 13, 2024, 04:00 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -0.21 | -0.06 | -0.18 | -0.20 | -0.56 | -0.43 | -5.08 | -5.89 | -17.97 |
| PS Ratio | 14.11 | 4.51 | 0.89 | 2.44 | 88.87 | 2.10 | 32.26 | 122.88 | 0.00 |
| PB Ratio | 0.07 | 0.07 | 0.27 | 1.37 | 0.57 | 0.17 | -2.59 | -2.81 | -5.19 |
| P/FCF Ratio | -0.24 | -0.07 | -0.23 | -0.37 | -0.60 | -0.42 | -5.23 | -35.67 | -19.80 |
| P/OCF Ratio | -0.24 | -0.07 | -0.23 | -0.37 | -0.60 | -0.42 | -5.23 | -36.15 | -19.80 |
| OCF/S Ratio | -14.94 | -15.30 | -0.96 | -1.63 | -36.74 | -1.24 | -1.54 | -0.85 | 0.00 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 3.18 | 1.02 | 0.76 | 0.93 | 1.80 | 3.65 | 2.14 | 2.02 | 14.25 |
| Current Ratio | 3.18 | 1.02 | 0.86 | 1.02 | 1.84 | 3.65 | 2.04 | 2.02 | 14.25 |
| Asset Turnover | 0.00 | 0.01 | 0.22 | 0.22 | 0.01 | 0.08 | 0.07 | 0.02 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | -3.03 | -6.46 | -7.51 | -4.41 | -14.31 | 0.00 | 0.00 |
| Return on Equity (ROE) | -32.06% | -108.79% | -150.77% | -681.64% | -102.86% | -39.46% | 50.98% | 47.78% | 28.88% |
| Return on Assets (ROA) | -29.13% | -83.28% | -109.37% | -272.63% | -89.00% | -36.77% | -43.48% | -33.45% | -10.50% |
| Return on Capital (ROIC) | -32.46% | -109.17% | -139.88% | -156.97% | -111.29% | -41.83% | -50.12% | -37.57% | -10.69% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | 25.00% | 25.00% | 19.33% | 23.34% | 5.25% | 25.00% | 25.00% | 25.00% | 0.00% |
| Net Profit Margin | -1677.59% | -1779.09% | -124.24% | -304.35% | -3976.52% | -120.88% | -158.64% | -521.81% | 0.00% |